Target

c-KIT

30 products, 32 indications

Indications
glioblastoma (6 products)
Platinum-resistant recurrent ovarian carcinoma (3 products)
ovarian cancer (2 products)
Advanced soft tissue sarcoma (2 products)
Advanced NSCLC with EGFR mutation (2 products)
Newly diagnosed glioblastoma or anaplastic astrocytoma (2 products)
advanced non-squamous NSCLC (2 products)
KIT-mutated melanoma (1 products)
Melanoma and Merkel Cell Carcinoma (1 products)
GIST (1 products)
Newly diagnosed Ph+ ALL (1 products)
metastatic non-small cell lung cancer (1 products)
Stage III melanoma (1 products)
NSCLC (1 products)
ROS1-rearranged NSCLC (1 products)
RET fusion-positive NSCLC (1 products)
Stage III unresectable NSCLC with EGFR mutations (1 products)
BRAF-mutant NSCLC (1 products)
unresectable platinum resistant ovarian cancer (1 products)
Relapsed or refractory ovarian cancer (1 products)
extensive-stage SCLC (1 products)
HER2-negative, hormone-receptor positive metastatic breast cancer (1 products)
Triple-negative breast cancer (1 products)
HER2-low metastatic breast cancer (1 products)
Resectable NSCLC (1 products)
non-G12C KRAS-mutant non-small cell lung cancer (1 products)
hepatocellular carcinoma (1 products)
recurrent advanced ovarian cancer (1 products)
EGFR-negative refractory advanced NSCLC (1 products)
platinum-resistant ovarian clear cell carcinoma (1 products)
metastatic melanoma (1 products)
mucosal melanoma (1 products)
Loading...

3 drugs